It has a powerful effect on TGF-β production through several mechanisms: negative regulation of TGF-β E-box repressor –Zeb1/2 and targeting of Smad-interacting protein 1 (SIP1), which is another E-box repressor; another mechanism is represented by hyperglycemia (diagnosed in half of our patients). The gene discussed is ZEB1; the disease is Hyperglycemia.